Nkarta, Inc.

Nkarta, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.

Company Details

Employees
147
Founded
-
Address
1150 Veterans Blvd., South San Francisco,california 94080,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
South San Francisco, California
Looking for a particular Nkarta, Inc. employee's phone or email?

Nkarta, Inc. Questions

News

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - GlobeNewswire

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting GlobeNewswire

The Supreme Court doesn’t belong in your medicine cabinet - statnews.com

The Supreme Court doesn’t belong in your medicine cabinet statnews.com

Nkarta Appoints Alyssa Levin Chief Financial and Business Officer - Yahoo Finance

Nkarta Appoints Alyssa Levin Chief Financial and Business Officer Yahoo Finance

Clinical-Stage NK Cell Therapy Pioneer Nkarta to Share Updates at Major Healthcare Conference - Stock Titan

Clinical-Stage NK Cell Therapy Pioneer Nkarta to Share Updates at Major Healthcare Conference Stock Titan

Alyssa Levin | People on The Move - San Francisco Business Times - The Business Journals

Alyssa Levin | People on The Move - San Francisco Business Times The Business Journals

Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials - GlobeNewswire

Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials GlobeNewswire

Nkarta Therapeutics Expands Management Team and Establishes New Corporate Headquarters - GlobeNewswire

Nkarta Therapeutics Expands Management Team and Establishes New Corporate Headquarters GlobeNewswire

Top Nkarta, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant